The correlation between angiogenesis and abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure, and improvement by puerarin (Phytotheraphy Research (2008) 22, 7 (948-956) DOI:10.1002/ptr.2437);The correlation between angiogenesis and abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure, and improvement by puerarin

Phytotherapy Research

Volumn 22, Issue 7, 2008, Pages 948-956

  He, Haibo ^a   Shi, Mengqiong ^b   Yang, Jun ^a   Zeng, Xiaowei ^a   Qiao, Hongxiang ^a   Wu, Limao ^a,c   Li, Lianda ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Center of Medical Science Analysis   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Angiogenesis pathway; ET ROS pathway; Heart failure; PLB; Puerarin; SERCA2a

Indexed keywords

ENDOTHELIN; MESSENGER RNA; PHOSPHOLAMBAN; PUERARIN; REACTIVE OXYGEN METABOLITE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; ECHOCARDIOGRAPHY; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART PERFORMANCE; HISTOLOGY; HYPOTHESIS; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; UPREGULATION;

RATTUS;

EID: 48749115958     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2884     Document Type: Erratum

References (36)

1. Adamson PB, Vanoli E. 2001. Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ischemic heart failure: characteristics of a novel heart failure model in dogs with postmyocardial infarction left ventricular dysfunction. J Am Coll Cardiol 37: 1741-1748.
2. del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ. 2002. Targeting phospholamban by gene transfer in human heart failure. Circulation 105: 904-907.
3. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN. 2006. Angio-genesis: from plants to blood vessels. Trends Pharmacol Sci 27: 297-309.
4. Francis B, Winaver J, Karram T, Hoffman A, Abassi Z. 2004. Renal and systemic effects of chronic blockade of ETA or ETB receptors in normal rats and animals with experimental heart failure. J Cardiovasc Pharmacol 44: S54-S58.
5. Freedman S, Isner JM. 2001. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 33: 379-393.
6. Gao Q, Pan HY, Xia Q, Bruce I. 2005. Improvement of ventricular mechanical properties by puerarin involves mitochondrial permeability transition in isolated rat heart during ischemia and reperfusion. Conf Proc IEEE Eng Med Biol Soc 6: 5591-5594.
7. Gianni D, Chan J, Gwathmey J K, del Monte F, Hajjar R J. 2005. SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr 37: 375-380.
8. Gotze S, Butter C, Fleck E. 2006. Cardiac resynchronization therapy for heart failure -from experimental pacing to evidence-based therapy. Clin Res Cardiol 95 (Suppl 4): 18-35.
9. Guo XG, Chen JZ, Zhang X, Xia Q. 2004. Effect of puerarin on L-type calcium channel in isolated rat ventricular myocytes. Zhongguo Zhong Yao Za Zhi 29: 248-251.
10. He HB, Dai DZ, Dai Y. 2006. CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats. Acta Pharmacol Sin 27: 1213-1221.
11. He HB, Yu F, Dai DZ, Dai Y. 2007. Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway. J Pharm Pharmacol 59: 977-984.
12. Henry TD, Annex BH, McKendall GR et al. 2003. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107: 1359-1365.
13. Ji XY, Tan BKH, Zhu YC, Lin ZW, Zhu YZ. 2003. Comparison of cardioprotective effects using ramipril and Danshen for the treatment of acute myocardial infarction in rats. Life Sci 73: 1413-1426.
14. Kastrup J, Jorgensen E, Ruck A et al. 2005. Direct intramyocardial plasmid vascular endothelial growth factor-a165 gene therapy in patients with stable severe angina pectoris a randomized double-blind placebo-controlled study: the Euroinject One Trial. J Am Coll Cardiol 45: 982-988.
15. B receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins. Am J Physiol Heart Circ Physiol 287: H1194-H1199.
16. Liu Q, Dai DZ. 2004. Influence of a new endothelin receptor antagonist CPU20213 on expression of mRNA of MMPs and TIMPs in hypertrophic myocardium induced by L-thyroxin in rats. Chin J Basal Clin Pharmacol Ther 9: 281-284.
17. MacLennan DH, Kranias EG. 2003. Phospholamban: a crucial regulator of cardiac contractility. Nature Rev Mol Cell Biol 4: 566-577.
18. Morgan EE, Faulx MD, McElfresh TA et al. 2004. Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 287: H2049-H2053.
19. Nagaya N, Uematsu M, Kojima M et al. 2001. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104: 1430-1435.
20. Nicosia RF, Nicosia SV, Smith M. 1994. Vascular endothelial growth factor, platelet-derived growth factor, and insulinlike growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145: 1023-1029.
21. Olson EN. 2004. A decade of discoveries in cardiac biology. Nat Med 10: 467-474.
22. Pearlman JD, Hibberd MG, Chuang ML et al. 1995. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1: 1085-1089.
23. Purdham DM, Zou MX, Rajapurohitam V, Karmazyn M. 2004. Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol 287: H2877-H2884.
24. Qi MY, Xia HJ, Dai DZ, Dai Y. 2006. A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats. J Cardiovasc Pharmacol 47: 729-735.
25. Shyu K, Wang MT, Wang BW et al. 2002. Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res 54: 576-583.
26. Sticherling C, Schaer B, Coenen M, Kuhne M, Ammann P, Osswald S. 2006. Cardiac resynchronization therapy in chronic heart failure. Swiss Med Wkly 136: 611-617.
27. Sumi M, Sata M, Toya N, Yanaga K, Ohki T, Nagai R. 2007. Transplantation of adipose stromal cells, but not mature adipocytes, augments ischemia-induced angiogenesis. Life Sci 80: 559-565.
28. Thomsen MB, Truin M, van Opstal JM et al. 2005. Sudden cardiac death in dogs with remodeled hearts is associated with larger beat-to-beat variability of repolarization. Basic Res Cardiol 100: 279-287.
29. Tsuruda T, Jougasaki M, Boerrigter G et al. 2002. Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor. Circ Res 90: 128-134.
30. Ushio-Fulai M. 2007. VEGF signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 9: 731-739.
31. Vandervelde S, van Luyu MJA, Tio RA, Harmsen MC. 2005. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 39: 363-376.
32. Wu LM, Qiao HX, Li YK, Li LD. 2007. Cardioprotective effects of the combined use of puerarin and danshensu on acute ischemic myocardial injury in rats. Phytother Res 21: 751-756.
33. Xie RQ, Du J, Hao YM. 2003. Myocardial protection and mechanism of puerarin injection on patients of coronary heart disease with ischemia/reperfusion. Zhongguo Zhongxi Yi Jie He Zazhi 23: 895-897.
34. Zhang SY, Chen SL, Shen YJ et al. 2006a. Puerarin induces angiogenesis in myocardium of Rat with myocardial infarction. Biol Pharm Bull 29: 945-950.
35. Zhang FR, Chen JZ, Zhu JH et al. 2004. Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Zhongguo Zhong Yao Za Zhi 29: 777-781.
36. kl in rat cardiac myocytes. J Fourth Mil Med Univ 27: 249-251.